Tag: XXII

Finance

Watch List: PT Telekomunikasi Indonesia (NYSE:TLK), 22nd Century Group (NYSEMKT:XXII), xG Technology, Inc. (NASDAQ:XGTI), E-Commerce China Dangdang (NYSE:DANG), Duke Energy (NYSE:DUK)

On 22 JULY PT Telekomunikasi Indonesia Tbk (NYSE:TLK) said that Thales Alenia Space has signed a contract with Indonesian company PT Telekomunikasi Indonesia Tbk (NYSE:TLK) to build a new telecommunications satellite. PT Telekomunikasi Indonesia Tbk (NYSE:TLK) belongs to Technology sector. Its net profit margin is 16.90% and weekly performance is 1.74%. On last trading day company shares ended up $46.24. PT Telekomunikasi Indonesia Tbk (NYSE:TLK) … Continue reading Watch List: PT Telekomunikasi Indonesia (NYSE:TLK), 22nd Century Group (NYSEMKT:XXII), xG Technology, Inc. (NASDAQ:XGTI), E-Commerce China Dangdang (NYSE:DANG), Duke Energy (NYSE:DUK)

Mark Doerr
Finance

Volatile Stocks: Prosensa Holding (NASDAQ:RNA), 22nd Century Group Inc (NYSEMKT:XXII), Alnylam Pharmaceuticals (NASDAQ:ALNY), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)

Prosensa Holding NV (NASDAQ:RNA) was upgraded by stock analysts at KBC Securities from a “hold” rating to an “accumulate” rating in a report issued on Wednesday. The firm currently has a $11.00 price objective on the stock, up from their previous price objective of $7.00. KBC Securities’ target price would indicate a potential upside of 1.57% from the company’s current price. Prosensa Holding NV (NASDAQ:RNA) … Continue reading Volatile Stocks: Prosensa Holding (NASDAQ:RNA), 22nd Century Group Inc (NYSEMKT:XXII), Alnylam Pharmaceuticals (NASDAQ:ALNY), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)

Colin Pettis
Finance

Biotech Decliners: Insmed Incorporated (NASDAQ:INSM), 22nd Century Group Inc (NYSEMKT:XXII), Concert Pharmaceuticals Inc (NYSE:JMPC), Relypsa Inc (NASDAQ:RLYP)

Insmed Incorporated (NASDAQ:INSM) on May 13, 2014 announces that multiple posterpresentations reporting data on ARIKAYCE(TM), or liposomal amakacinfor inhalation, for the treatment of Pseudomonas aeruginosainfections in cystic fibrosis (CF) patients and for the treatment ofpatients with treatment-resistant nontuberculous mycobacterial (NTM)lung infections will be presented at the American Thoracic SocietyAnnual Meeting 2014, taking place May 16-21 in San Diego, California. Insmed Incorporated (NASDAQ:INSM) stock performance was … Continue reading Biotech Decliners: Insmed Incorporated (NASDAQ:INSM), 22nd Century Group Inc (NYSEMKT:XXII), Concert Pharmaceuticals Inc (NYSE:JMPC), Relypsa Inc (NASDAQ:RLYP)

Kevin Long
Finance

Most Volatile Biotech Stocks: IGI Laboratories (NYSEMKT:IG), 22nd Century Group (NYSEMKT:XXII), PharmAthene (NYSEMKT:PIP), Pacific Biosciences of California (NASDAQ:PACB)

IGI Laboratories, Inc. (NYSEMKT:IG), a New Jersey-based generic topical pharmaceutical company, today announced that it has appointed Damian Finio to its Board of Directors. Mr. Finio will serve as the new Chairman of the Company’s Audit Committee. IGI Laboratories, Inc. (NYSEMKT:IG) stock performance was -10.79% in last session and finished the day at $4.88. Traded volume was 447,080.00million shares in the last session and the … Continue reading Most Volatile Biotech Stocks: IGI Laboratories (NYSEMKT:IG), 22nd Century Group (NYSEMKT:XXII), PharmAthene (NYSEMKT:PIP), Pacific Biosciences of California (NASDAQ:PACB)

Jason Knox
Finance

Unusual Volume At Biotech Stocks: Aastrom Biosciences (NASDAQ:ASTM), 22nd Century Group (NYSEMKT:XXII), Dyax Corp. (NASDAQ:DYAX), Exelixis (NASDAQ:EXEL)

Over the past few trading days, sleepy microcap Aastrom Biosciences Inc (NASDAQ:ASTM) has exploded from $3.88 3/19/14 to a peak of $6.24 after a positive article from respected analyst Jason Napodano. Seeking Alpha’s sophisticated readership is more than capable of analyzing Aastrom Biosciences Inc (NASDAQ:ASTM)’s balance sheet. Aastrom Biosciences Inc (NASDAQ:ASTM) stock performance was -15.21% in last session and finished the day at $4.18. Traded … Continue reading Unusual Volume At Biotech Stocks: Aastrom Biosciences (NASDAQ:ASTM), 22nd Century Group (NYSEMKT:XXII), Dyax Corp. (NASDAQ:DYAX), Exelixis (NASDAQ:EXEL)

Colin Pettis
Finance

Biotech Losers: Geron Corporation (NASDAQ:GERN), OXiGENE Inc (NASDAQ:OXGN), Opexa Therapeutics Inc (NASDAQ:OPXA), 22nd Century Group Inc (NYSEMKT:XXII)

Brower Piven, A Professional Corporation on Mar. 18 announced that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of purchasers of Geron Corporation (NASDAQ:GERN) securities during the period between June 16, 2013 and March 11, 2014, inclusive (the “Class Period”). Geron Corporation (NASDAQ:GERN) stock performance was -8.06% in last session and finished … Continue reading Biotech Losers: Geron Corporation (NASDAQ:GERN), OXiGENE Inc (NASDAQ:OXGN), Opexa Therapeutics Inc (NASDAQ:OPXA), 22nd Century Group Inc (NYSEMKT:XXII)

Jason Knox